Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

BACKGROUND: Although the introduction of novel agents improved the survival outcomes in patients with multiple myeloma (MM), some patients died within one year (early mortality, EM) following diagnosis. In this study, we evaluated the EM rate, and investigated the risk factors associated with EM in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Jung, Sung-Hoon, Cho, Min-Seok, Kim, Hee Kyung, Kim, Seok Jin, Kim, Kihyun, Cheong, June-Won, Kim, Soo-Jeoong, Kim, Jin Seok, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Lee, Je-Jung
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977683/
https://ncbi.nlm.nih.gov/pubmed/27501959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2645-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars